Clinical Trials Sponsored by Xun Xu

Total 3978 results

Sun Yat-sen University

Recruiting

Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

Hepatocellular Carcinoma

China
Sun Yat-sen University

Recruiting

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

Gastric Cancer

China
Sun Yat-sen University

Recruiting

Wise Practice of Chinese Hemodialysis (WISHES)

Haemolyses and Related Conditions

China
Sun Yat-sen University

Recruiting

Super Chinese Nephrotic Syndrome Registration System (SUCCESS)

Nephrotic Syndrome

China
Sun Yat-sen University

Recruiting

IgA Nephropathy Biomarkers Evaluation Study (INTEREST) (INTEREST)

IgA Nephropathy | Glomerular Diseases

China
Sun Yat-sen University

Recruiting

A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations

EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors

China
Sun Yat-sen University

Recruiting

Esthetic, Clinical and Radiographic Outcomes of Immediate and Delayed Implant Placement

Jaw, Edentulous, Partially | Acquired Absence of Single Tooth

China
Sun Yat-sen University

Recruiting

A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas (β-elemene)

Glioblastoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma

China
Sun Yat-sen University

Recruiting

A Prospective Multi-center Phase III Randomized Controlled Trial (NACA)

Carcinoma，Non-Small-Cell Lung

China
Sun Yat-sen University

Recruiting

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

Lymphoma, Lymphoblastic

China
Sun Yat-sen University

Recruiting

A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment

Non-small Cell Lung Cancer (NSCLC) | EGFR-TKI Resistant Mutation | EGFR-TKI Sensitizing Mutation | Somatic Mutation | Germline Mutations

China
Sun Yat-sen University

Recruiting

Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma

Astrocytoma | Oligodendroglioma | Oligodendroastrocytoma

China
Sun Pharmaceutical Industries Limited

Active, not recruiting

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

Active Psoriatic Arthritis

United States, Australia, Czechia, Germany, India, Japan, Korea, Republic of, Poland, Spain
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition

Endocrine, Nutritional and Metabolic Diseases

Korea, Republic of
Sun Yat-sen University

Active, not recruiting

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

Stage III Non-small-cell Lung Cancer

China
Sun Yat-sen University

Completed

Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients

Breast Cancer

China
Sun Yat-sen University

Completed

The Risk Assessment Scale for Peripherally Inserted Central Venous Catheter (PICC) Related Thrombosis in Cancer Patients

Thrombosis | Catheter

China
Rao Sun

Completed

Machine Learning Models for Prediction of Acute Kidney Injury After Noncardiac Surgery

Postoperative Acute Kidney Injury

China
Xin Wang

Completed

Construction and Effect Evaluation of the Low Load Blood Flow Restriction Training Program for Lung Cancer Patients Complicated With Sarcopenia During Chemotherapy

Lung Neoplasms | Sarcopenia

China
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)

Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)

Hypertension | Dyslipidemias

Korea, Republic of
Sun Yat-sen University

Completed

Characteristics and Tumor Staging Proposal for Primary Malignant Melanoma of the Esophagus

Primary Malignant Melanoma of the Esophagus

China
Sun Yat-sen University

Active, not recruiting

Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer (MECCA)

Breast Cancer

China
Sun Yat-sen University

Active, not recruiting

Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Sun Yat-sen University

Completed

Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Sun Pharmaceutical Industries Limited

Completed

Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.

Psoriatic Arthritis

United States, Argentina, Hungary, Mexico, Poland, Russian Federation, Spain, Ukraine
Chong Kun Dang Pharmaceutical

Completed

Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150

Type 2 Diabetes

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)

Hypertension and Dyslipidemia

Korea, Republic of
Sun Yat-sen University

Completed

A Conversational AI System to Enhance Knowledge About Vaccines and Promote Vaccination

Vaccination Hesitancy

China
Sun Yat-sen University

Completed

Efficacy of Using Large Language Model to Assist in Diabetic Retinopathy Detection

Diabetic Retinopathy | Diagnosis

China
Sun Yat-sen University

Active, not recruiting

Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)

Esophageal Anastomotic Leak

China
Sun Yat-sen University

Active, not recruiting

SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer (SACTION01)

Carcinoma, Non-Small-Cell Lung

China
Sun Yat-sen University

Active, not recruiting

A Study of Cadonilimab Combined With Regorafenib in Patients With Advanced HCC

Advanced Hepatocellular Carcinoma

China
Sun Yat-sen University

Completed

Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung Cancer

Local Advanced Non-small Cell Lung Cancer

China
Sun Yat-sen University

Active, not recruiting

The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Enrolling by invitation

Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator

Rectal Cancer

China
Rao Sun

Completed

Preoperative Inflammatory Status and Postoperative Acute Kidney Injury

Postoperative Acute Kidney Injury

China
Sun Yat-sen University

Completed

Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell Carcinoma

Carcinoma, Renal Cell
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg

Hypertension and Dyslipidemia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg

Hypertension

Korea, Republic of
Sun Yat-sen University

Active, not recruiting

TNT to Increase the Clinical Complete Response Rate for Distal LARC (TESS)

Chemoradiation | Rectal Cancer | Rectal Cancer Stage II | Rectal Cancer Stage III

China
Sun Yat-sen University

Active, not recruiting

Follow-up Strategy for Esophageal Cancer Patients

Esophagus Cancer

China
Sun Yat-sen University

Completed

Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLC

Non-small Cell Lung Cancer

China
Chong Kun Dang Pharmaceutical

Active, not recruiting

Study to Evaluate the Safety and Pharmacokinetics of CKD-379

Type II Diabetes Mellitus

Korea, Republic of
Sun Yat-sen University

Completed

Vitamin C Intravenously With Chemotherapy in Advanced Colorectal Cancer (Vitality)

Colorectal Neoplasms

China
Sun Yat-sen University

Active, not recruiting

Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation Study

Nasopharyngeal Cancer

China
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348

Hypertension and Dyslipidemia

Korea, Republic of
Sun Yat-sen University

Active, not recruiting

Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma

Hepatocellular Carcinoma (HCC) | Radiomics | Transcatheter Arterial Chemoembolization (TACE) | Microvascular Invasion (MVI) | Multi-kinase Inhibitors (MKI)

China
Sun Yat-sen University

Completed

Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC

Brain Metastases | NSCLC Stage IV | PD-1 Antibody

China
Chong Kun Dang Pharmaceutical

Completed

Pharmacokinetics and Safety/Tolerability of CKD-379

Type II Diabetes Mellitus

Korea, Republic of

3

Subscribe